{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:12:28Z","timestamp":1761765148018,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.canrad.2009.01.002","type":"journal-article","created":{"date-parts":[[2009,4,7]],"date-time":"2009-04-07T06:19:02Z","timestamp":1239085142000},"page":"205-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Toxicit\u00e9 de l\u2019association radioth\u00e9rapie et antiangiog\u00e9niques\u00a0: \u00e0 propos d\u2019un cas"],"prefix":"10.1016","volume":"13","author":[{"given":"O.","family":"Diaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Mazeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Carrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2009.01.002_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0360-3016(97)00101-6","article-title":"Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck","volume":"38","author":"Brizel","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.01.002_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.canrad.2009.01.002_bib3","first-page":"5565","article-title":"Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions","volume":"60","author":"Lee","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2009.01.002_bib4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.gcb.2008.01.042","article-title":"Antiangiogenic agents and gastrointestinal cancers","volume":"32","author":"Li\u00e8vre","year":"2008","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.canrad.2009.01.002_bib5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.ijrobp.2005.12.004","article-title":"Increased risk of ischemic bowel complications during treatment with bevacizumab after pelvic irradiation: Report of three cases","volume":"64","author":"Lordick","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.01.002_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.canrad.2007.12.002","article-title":"Angiogen\u00e8se et radioth\u00e9rapie\u00a0: tout ce qu\u2019un oncologue radioth\u00e9rapeute doit savoir","volume":"12","author":"Mazeron","year":"2008","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2009.01.002_bib7","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1200\/JCO.1997.15.5.2097","article-title":"Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study","volume":"15","author":"Perng","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2009.01.002_bib8","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1200\/JCO.2007.15.8451","article-title":"Bowel perforation after radiotherapy in a patient receiving sorafenib","volume":"26","author":"Peters","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2009.01.002_bib9","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1158\/0008-5472.CAN-07-1473","article-title":"Cell cycle dependent and schedule-dependent antitumor effects of sorafenib combined with radiation","volume":"67","author":"Plastaras","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2009.01.002_bib10","first-page":"A1923","article-title":"Gemzar\u00ae (gemcitabine) with thoracic radiotherapy \u2014 a phase II pilot study in chemonaive patients with advanced non-small cell lung cancer","volume":"17","author":"Scalliet","year":"1998","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.canrad.2009.01.002_bib11","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1158\/0008-5472.CAN-04-3379","article-title":"Enhanced susceptibility of irradiated tumor vessels to vascular endothelial growth factor receptor tyrosine kinase inhibition","volume":"65","author":"Zips","year":"2005","journal-title":"Cancer Res"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321809000134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321809000134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:14:57Z","timestamp":1761135297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321809000134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S1278321809000134"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2009.01.002","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicit\u00e9 de l\u2019association radioth\u00e9rapie et antiangiog\u00e9niques\u00a0: \u00e0 propos d\u2019un cas","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2009.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}